Jump Financial, LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1831577 Chicago, IL

Position in NRIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$4,143,316

+$2,755,787 QoQ

Shares Held

170,788

+90.8% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#67

of 210 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. NRIX ranks #35 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,143,316	170,788	+90.8%	Shares	Defined	2026-08-13
2026-03-31	$1,387,529	89,518	+11.8%	Shares	Defined	2026-05-14
2025-12-31	$1,518,300	80,037	+5.2%	Shares	Defined	2026-02-17
2025-03-31	$903,592	76,060	+1.9%	Shares	Defined	2025-05-14
2024-12-31	$1,405,821	74,619	+386.7%	Shares	Defined	2025-02-13
2023-12-31	$158,226	15,332	+26.7%	Shares	Sole	2024-10-21
2023-03-31	$107,448	12,100	-52.1%	Shares	Sole	2024-10-21
2022-12-31	$277,497	25,273	-42.3%	Shares	Sole	2023-02-14
2022-09-30	$570,714	43,800	+15.3%	Shares	Sole	2022-11-07
2022-06-30	$481,460	38,000	+18.1%	Shares	Sole	2022-08-09
2022-03-31	$450,603	32,163	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.